2Wise R Hoevbourae B.A.review of the penetration of sparfloxacin into tower respiratory tract and sinuses [J] ,J Amtimicrob chemother 1996:37(supple A) :57.
3Bagucro F,canton R. In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory, tract pathogens [J ] .Antimicrob chemother 1996 ;37 (supple A) : 1.
4杨树勤主编.《卫生统计学》第二版.北京：人民卫生出版社1994年：218-219.
5Kojima T,et al. In vitro activity of AT-4140 agannst clinical bacterial isolates. Antimicrobial Agents and Chemotherapy, 1989,33(11):1980
6Cooper M A,et al. In vitro activity of sparfloxacin,a new quinolone antimicrobial agent. J Antimicrobial Chemotherapy,1990,26:667
7Nakamura S,et al. In vitro and in vivo antibacterial activities of AT - 4140,a new broad - spectrum quinolone. Antimicrobial Agents and Chemotherapy, 1989,33(8): 1167
